Skip to main content

Pharmacare bill passes in the House of Commons, heads to the Senate

Minister of Health Mark Holland speaks about new national pharmacare legislation during a press conference in Ottawa on Thursday, Feb. 29, 2024. (Patrick Doyle/The Canadian Press)
Minister of Health Mark Holland speaks about new national pharmacare legislation during a press conference in Ottawa on Thursday, Feb. 29, 2024. (Patrick Doyle/The Canadian Press)
Share

The Liberals' pharmacare bill is headed to the Senate after passing third reading in the House of Commons. 

The bill was the result of careful and lengthy negotiations between the Liberals and the New Democrats as a key element of their political pact to prevent an early election.

The legislation would see the federal government offer first-payer coverage of some contraceptive and diabetes medications, and sets the stage for a future full-fledged universal pharmacare program.

It's not yet clear exactly what drugs will be covered, since they will be the subject of negotiations with provincial and territorial governments.

Once the bill is passed, Health Minister Mark Holland can begin those formal negotiations with provinces and territories to deliver the program, which is expected to cost $1.5 billion over five years. 

The goal is that Canadians will be able to access the contraceptive or diabetes drugs or supplies by showing their health card, whether they have insurance coverage or not. 

This report by The Canadian Press was first published June 3, 2024

IN DEPTH

Opinion

opinion

opinion Don Martin: How a beer break may have doomed the carbon tax hike

When the Liberal government chopped a planned beer excise tax hike to two per cent from 4.5 per cent and froze future increases until after the next election, says political columnist Don Martin, it almost guaranteed a similar carbon tax move in the offing.

CTVNews.ca Top Stories

Local Spotlight

Stay Connected